Literature DB >> 11399647

HGF promotes adhesion of ATP-depleted renal tubular epithelial cells in a MAPK-dependent manner.

Z X Liu1, C H Nickel, L G Cantley.   

Abstract

Hepatocyte growth factor (HGF) has been shown to enhance recovery from renal tubular ischemia. We investigated the possibility that HGF improves recovery by preventing ischemia-induced loss of cell adhesion. Murine inner medullary collecting duct-3 (mIMCD-3) cells subjected to 90% ATP depletion demonstrated a 55% decrease in adhesion, an effect that was completely reversed by the addition of HGF. Assays examining release of adherent cells revealed similar results with 30 min of ATP depletion causing loss of adhesion of 25% of mIMCD-3 cells and HGF completely reversing this effect. In contrast, HGF was unable to reverse the loss of adhesion of cells exposed to 99% ATP depletion. Examination of the mitogen-activated protein kinase (MAPK) signaling pathway revealed that HGF could induce extracellular signal-regulated kinase (ERK) phosphorylation in control and 90% ATP-depleted cells but not in 99% ATP-depleted cells. Inhibition of ERK activation with U0126 completely blocked the HGF-dependent reversal of ATP-depleted cell adhesion. Thus ATP-depleted cells demonstrate a marked decrease in cell adhesion that is reversible by the addition of HGF. This effect of HGF requires activation of the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399647     DOI: 10.1152/ajprenal.2001.281.1.F62

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  9 in total

1.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

Review 3.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

4.  Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells.

Authors:  Grazyna Nowak; Ginger L Clifton; Malinda L Godwin; Diana Bakajsova
Journal:  Am J Physiol Renal Physiol       Date:  2006-05-16

5.  Exocyst Sec10 protects epithelial barrier integrity and enhances recovery following oxidative stress, by activation of the MAPK pathway.

Authors:  Kwon Moo Park; Ben Fogelgren; Xiaofeng Zuo; Jinu Kim; Daniel C Chung; Joshua H Lipschutz
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06

6.  Met activation is required for early cytoprotection after ischemic kidney injury.

Authors:  Sherene Mason; Carlos Hader; Arnaud Marlier; Gilbert Moeckel; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

7.  Pinocembrin protects human brain microvascular endothelial cells against fibrillar amyloid-β(1-40) injury by suppressing the MAPK/NF-κB inflammatory pathways.

Authors:  Rui Liu; Jin-ze Li; Jun-ke Song; Jia-lin Sun; Yong-jie Li; Si-bai Zhou; Tian-tai Zhang; Guan-hua Du
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

8.  Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury.

Authors:  Amrita Dosanjh; Elizabeth Robison; Tony Mondala; Steven R Head; Daniel R Salomon; Sunil M Kurian
Journal:  BMC Genomics       Date:  2013-04-23       Impact factor: 3.969

9.  Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury.

Authors:  Dong Zhou; Roderick J Tan; Lin Lin; Lili Zhou; Youhua Liu
Journal:  Kidney Int       Date:  2013-05-29       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.